Sex
Cardiovascular History from H&P- Overall CV Endorsement: (0=None, 1=Resolved, 2=Ongoing) vs Visit (Number)
Baseline (BL) | Clinical Evaluation (CE) | Diagnostic Visit (DX) | CPAP Titration Visit (CPAP) | Two Month Post-CPAP Neurocognitive Visit (2M) | Four Month Post-CPAP Neurocognitive Visit (4M) | Six Month Post-CPAP Neurocognitive Visit (6M) | |
---|---|---|---|---|---|---|---|
Total | 1,516 | 1,516 | 1,516 | 1,516 | 1,516 | 1,516 | 1,516 |
None | 927 | - | - | - | - | - | - |
Resolved | 558 | - | - | - | - | - | - |
Ongoing | - | - | - | - | - | - | - |
Accidental skip | 29 | - | - | - | - | - | - |
Refused by Subject | 2 | - | - | - | - | - | - |
Unknown | - | 1,516 | 1,516 | 1,516 | 1,516 | 1,516 | 1,516 |
Cardiovascular History from H&P- Overall CV Endorsement: (0=None, 1=Resolved, 2=Ongoing) vs Gender
Baseline (BL)
Male | Female | Total | |
---|---|---|---|
Total | 958 | 558 | 1,516 |
None | 597 | 330 | 927 |
Resolved | 339 | 219 | 558 |
Ongoing | - | - | - |
Accidental skip | 20 | 9 | 29 |
Refused by Subject | 2 | - | 2 |
Cardiovascular History from H&P- Overall CV Endorsement: (0=None, 1=Resolved, 2=Ongoing) vs Gender
Clinical Evaluation (CE)
Male | Female | Total | |
---|---|---|---|
Total | 958 | 558 | 1,516 |
None | - | - | - |
Resolved | - | - | - |
Ongoing | - | - | - |
Unknown | 958 | 558 | 1,516 |
Cardiovascular History from H&P- Overall CV Endorsement: (0=None, 1=Resolved, 2=Ongoing) vs Gender
Diagnostic Visit (DX)
Male | Female | Total | |
---|---|---|---|
Total | 958 | 558 | 1,516 |
None | - | - | - |
Resolved | - | - | - |
Ongoing | - | - | - |
Unknown | 958 | 558 | 1,516 |
Cardiovascular History from H&P- Overall CV Endorsement: (0=None, 1=Resolved, 2=Ongoing) vs Gender
CPAP Titration Visit (CPAP)
Male | Female | Total | |
---|---|---|---|
Total | 958 | 558 | 1,516 |
None | - | - | - |
Resolved | - | - | - |
Ongoing | - | - | - |
Unknown | 958 | 558 | 1,516 |
Cardiovascular History from H&P- Overall CV Endorsement: (0=None, 1=Resolved, 2=Ongoing) vs Gender
Two Month Post-CPAP Neurocognitive Visit (2M)
Male | Female | Total | |
---|---|---|---|
Total | 958 | 558 | 1,516 |
None | - | - | - |
Resolved | - | - | - |
Ongoing | - | - | - |
Unknown | 958 | 558 | 1,516 |
Cardiovascular History from H&P- Overall CV Endorsement: (0=None, 1=Resolved, 2=Ongoing) vs Gender
Four Month Post-CPAP Neurocognitive Visit (4M)
Male | Female | Total | |
---|---|---|---|
Total | 958 | 558 | 1,516 |
None | - | - | - |
Resolved | - | - | - |
Ongoing | - | - | - |
Unknown | 958 | 558 | 1,516 |
Cardiovascular History from H&P- Overall CV Endorsement: (0=None, 1=Resolved, 2=Ongoing) vs Gender
Six Month Post-CPAP Neurocognitive Visit (6M)
Male | Female | Total | |
---|---|---|---|
Total | 958 | 558 | 1,516 |
None | - | - | - |
Resolved | - | - | - |
Ongoing | - | - | - |
Unknown | 958 | 558 | 1,516 |
Cardiovascular History from H&P- Overall CV Endorsement: (0=None, 1=Resolved, 2=Ongoing) vs Race/Ethnicity
Baseline (BL)
Native American | Asian | Black | Hispanic | White | Other | Total | |
---|---|---|---|---|---|---|---|
Total | 28 | 89 | 172 | 116 | 1,102 | 9 | 1,516 |
None | 16 | 65 | 98 | 75 | 669 | 4 | 927 |
Resolved | 11 | 22 | 71 | 35 | 414 | 5 | 558 |
Ongoing | - | - | - | - | - | - | - |
Accidental skip | 1 | 2 | 3 | 6 | 17 | - | 29 |
Refused by Subject | - | - | - | - | 2 | - | 2 |
Cardiovascular History from H&P- Overall CV Endorsement: (0=None, 1=Resolved, 2=Ongoing) vs Race/Ethnicity
Clinical Evaluation (CE)
Native American | Asian | Black | Hispanic | White | Other | Total | |
---|---|---|---|---|---|---|---|
Total | 28 | 89 | 172 | 116 | 1,102 | 9 | 1,516 |
None | - | - | - | - | - | - | - |
Resolved | - | - | - | - | - | - | - |
Ongoing | - | - | - | - | - | - | - |
Unknown | 28 | 89 | 172 | 116 | 1,102 | 9 | 1,516 |
Cardiovascular History from H&P- Overall CV Endorsement: (0=None, 1=Resolved, 2=Ongoing) vs Race/Ethnicity
Diagnostic Visit (DX)
Native American | Asian | Black | Hispanic | White | Other | Total | |
---|---|---|---|---|---|---|---|
Total | 28 | 89 | 172 | 116 | 1,102 | 9 | 1,516 |
None | - | - | - | - | - | - | - |
Resolved | - | - | - | - | - | - | - |
Ongoing | - | - | - | - | - | - | - |
Unknown | 28 | 89 | 172 | 116 | 1,102 | 9 | 1,516 |
Cardiovascular History from H&P- Overall CV Endorsement: (0=None, 1=Resolved, 2=Ongoing) vs Race/Ethnicity
CPAP Titration Visit (CPAP)
Native American | Asian | Black | Hispanic | White | Other | Total | |
---|---|---|---|---|---|---|---|
Total | 28 | 89 | 172 | 116 | 1,102 | 9 | 1,516 |
None | - | - | - | - | - | - | - |
Resolved | - | - | - | - | - | - | - |
Ongoing | - | - | - | - | - | - | - |
Unknown | 28 | 89 | 172 | 116 | 1,102 | 9 | 1,516 |
Cardiovascular History from H&P- Overall CV Endorsement: (0=None, 1=Resolved, 2=Ongoing) vs Race/Ethnicity
Two Month Post-CPAP Neurocognitive Visit (2M)
Native American | Asian | Black | Hispanic | White | Other | Total | |
---|---|---|---|---|---|---|---|
Total | 28 | 89 | 172 | 116 | 1,102 | 9 | 1,516 |
None | - | - | - | - | - | - | - |
Resolved | - | - | - | - | - | - | - |
Ongoing | - | - | - | - | - | - | - |
Unknown | 28 | 89 | 172 | 116 | 1,102 | 9 | 1,516 |
Cardiovascular History from H&P- Overall CV Endorsement: (0=None, 1=Resolved, 2=Ongoing) vs Race/Ethnicity
Four Month Post-CPAP Neurocognitive Visit (4M)
Native American | Asian | Black | Hispanic | White | Other | Total | |
---|---|---|---|---|---|---|---|
Total | 28 | 89 | 172 | 116 | 1,102 | 9 | 1,516 |
None | - | - | - | - | - | - | - |
Resolved | - | - | - | - | - | - | - |
Ongoing | - | - | - | - | - | - | - |
Unknown | 28 | 89 | 172 | 116 | 1,102 | 9 | 1,516 |
Cardiovascular History from H&P- Overall CV Endorsement: (0=None, 1=Resolved, 2=Ongoing) vs Race/Ethnicity
Six Month Post-CPAP Neurocognitive Visit (6M)
Native American | Asian | Black | Hispanic | White | Other | Total | |
---|---|---|---|---|---|---|---|
Total | 28 | 89 | 172 | 116 | 1,102 | 9 | 1,516 |
None | - | - | - | - | - | - | - |
Resolved | - | - | - | - | - | - | - |
Ongoing | - | - | - | - | - | - | - |
Unknown | 28 | 89 | 172 | 116 | 1,102 | 9 | 1,516 |